British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy
Orexia and Inexia, two new virtual companies spun out of Sosei Heptares, will develop drugs…
February 6, 2019 - 2 minutes
Heptares Therapeutics
British Biotech Founder Receives the Nobel Prize in Chemistry 2017
Richard Henderson, awarded the Nobel Prize in Chemistry 2017, founded Heptares Therapeutics to apply his Nobel-winning technology…
October 5, 2017 - 2 minutes
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Allergan's partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat…
September 1, 2017 - 2 minutes
Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares
Heptares is expanding into a range of indications with its GPCR platform. I caught up…
July 17, 2017 - 6 minutes
A Painful Case: How Biotech is trying to Break Through in Analgesia
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great,…
June 6, 2017 - 7 minutes
Heptares receives €4.5M Milestone for New Migraine Drug Candidate
The UK biotech attacking notoriously evasive GPCRs has discovered a small molecule that could be…
May 18, 2017 - 1 minute
Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation
Heptares Therapeutics has published the detailed structure and mechanism of action of a difficult-to-target GPCR…
April 27, 2017 - 2 minutes
Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor
Heptares Therapeutics has achieved a new milestone in its immuno-oncology collaboration with AstraZeneca triggering an…
April 5, 2017 - 3 minutes
What are the Best Countries to Recruit Biotech Talents in 2017?
Before the “who to recruit” phase, an important question is “where?” We ran through the…
March 15, 2017 - 10 minutes
New British Biotech-Academia Alliance takes on Cardiovascular Disease
Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for…
January 31, 2017 - 2 minutes
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
December 26, 2016 - 5 minutes
Drugging the Undruggable: New Acquisition to Boost GPCR Drugs
Heptares Therapeutics has acquired G7 Therapeutics to take control over its GPCR technology, boost its…
November 30, 2016 - 2 minutes
